Lemon Healthcare, a smart hospital and medical data platform company, is drawing keen market attention as it begins its public stock offering for general investors on the 24th.

As of the early hours of the first day of subscription, the number of shares allocated through equal distribution stands at around 17 lots. However, it should be taken into account that the process is still in its early stages. Lemon Healthcare's general public subscription will take place over two days, from the 24th to the 25th.

■ Company & IPO Overview Lemon Healthcare operates key services including a smart hospital relay platform (LDB-H), a medical data ecosystem relay platform (LDB-D), and a customized health data relay platform (LDB-E), and is pursuing a listing on the KOSDAQ market.

The number of shares being offered in this IPO is 2 million, with a total offering amount of 20 billion KRW. The volume allocated to general investors is approximately 500,000 to 600,000 shares. The final IPO price was confirmed at 10,000 KRW, the upper end of the hoped-for range. KB Securities is the lead underwriter, and the listing date is scheduled for July 6.

■ Demand Forecast & Schedule During the institutional investor demand forecast conducted earlier (from the 15th to the 19th), it recorded a competition rate of 1,238 to 1, reflecting high interest.

Lemon Healthcare passed its preliminary screening review last year, received approval for its preliminary listing review this March, and has been undergoing the IPO process since submitting its securities registration statement in April.

The allotment results will be announced on the 29th, with payment and refund processes also taking place on the same day. Following this, full-fledged stock trading will begin through its listing on the KOSDAQ market.

■ Market Outlook In the recent IPO market, a trend of recovering investor sentiment has been emerging, centered on technology and platform companies, drawing attention to whether Lemon Healthcare's subscription will be a success.

[※ This article was written with the assistance of AI based on publicly available data and market information. The content included in this article serves as reference material for investment decisions and does not constitute a recommendation to buy or sell any specific stock or guarantee any returns. As the stock market can fluctuate due to various factors, investment decisions should be made based on the investor's own judgment and responsibility. Please be sure to verify disclosure materials and corporate announcements before making any final investment decisions.]

The IPO market continues to show strong interest in innovative healthcare technology companies.